3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Glioma
13
Astrocytoma
9
Brain Neoplasms
8
Neuroblastoma
6
Neoplasms
6
Gliosarcoma
6
Sarcoma, Ewing
4
Medulloblastoma
4
Rhabdomyosarcoma
3
Recurrence
3
Oligodendroglioma
3
Diffuse Intrinsic Pontine Glioma
3
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
trastuzumab deruxtecan
1
sacituzumab govitecan
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Temozolomide
×
30 days
×
Clear all
No trials found.